Reproductive endocrinology. Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report

By Olivennes F.  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1588-1591

Oxford University Press

Access to resources Recommend Favorite

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

By European Middle East Orgalutran® Study Group* The  

Human Reproduction, Vol. 16, Iss. 4, 2001-04 ,pp. : 644-651

Oxford University Press

Access to resources Recommend Favorite

Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation

By Bonduelle Maryse   Obery Janine   Mannaerts Bernadette   Devroey Paul  

Human Reproduction, Vol. 25, Iss. 6, 2010-06 ,pp. : 1433-1440

Oxford University Press

Access to resources Recommend Favorite

Timing of human chorionic gonadotropin trigger, in patients undergoing controlled ovarian hyperstimulation for IVF, using the GnRH antagonist protocol

By Orvieto Raoul  

Human Fertility, Vol. 15, Iss. 4, 2012-12 ,pp. : 221-221

Informa Healthcare

Access to resources Recommend Favorite

Infertility. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

By Itskovitz-Eldor J.   Kol S.  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1965-1968

Oxford University Press

Access to resources Recommend Favorite